Management of thyroid eye disease in the United Kingdom: A multi-centre thyroid eye disease audit
Autor: | C J MacEwen, Bijay Vaidya, Janis Hickey, James E. McLaren, FE Mellington, Petros Perros, G E Rose, JH Lazarus, Jimmy Uddin, Daniel G. Ezra, Anna L. Mitchell, A J Dickinson, P Foley, Colin M. Dayan |
---|---|
Rok vydání: | 2017 |
Předmět: |
Adult
Male Pediatrics medicine.medical_specialty Referral Eye disease 030209 endocrinology & metabolism Audit Health Services Accessibility Iodine Radioisotopes Young Adult 03 medical and health sciences 0302 clinical medicine Surveys and Questionnaires Humans Medicine Prospective Studies Multi centre Glucocorticoids Aged Aged 80 and over business.industry Thyroid Middle Aged medicine.disease United Kingdom Graves Ophthalmopathy Ophthalmology Cross-Sectional Studies medicine.anatomical_structure Patient Satisfaction 030221 ophthalmology & optometry Female Management Audit Observational study Level of care Thyroid function business |
Zdroj: | Orbit. 36:159-169 |
ISSN: | 1744-5108 0167-6830 |
Popis: | This article aims to provide baseline data and highlight any major deficiencies in the current level of care provided for adult patients with thyroid eye disease (TED). We undertook a prospective, nonrandomized cross-sectional multicenter observational study. During a 3-month period June–August 2014, consecutive adult patients with TED who presented to nominated specialist eye clinics in the United Kingdom, completed a standardized questionnaire. Main outcome measures were: demographics, time from diagnosis to referral to tertiary centre, time from referral to review in specialist eye clinic, management of thyroid dysfunction, radioiodine and provision of steroid prophylaxis, smoking, and TED classification. 91 patients (mean age 47.88 years) were included. Female-to-male ratio was 6:1. Mean time since first symptoms of TED = 27.92 (73.71) months; from first visit to any doctor with symptoms to diagnosis = 9.37 (26.03) months; from hyperthyroidism diagnosis to euthyroidism 12.45 (16.81) months. First, 13% had received radioiodine. All those with active TED received prophylactic steroids. Seven patients who received radioiodine and did not have TED at the time went on to develop it. Then, 60% patients were current or ex-smokers. 63% current smokers had been offered smoking cessation advice. 65% patients had active TED; 4% had sight-threatening TED. A large proportion of patients (54%) were unaware of their thyroid status. Not enough patients are being provided with smoking cessation advice and information on the impact of smoking on TED and control of thyroid function. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |